BABA vs BALL

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

The Advanced Deterministic Scorecard reveals significant concerns, most notably a weak Piotroski F-Score of 3/9, indicating poor financial health based on fundamental criteria. Despite strong recent earnings growth (YoY +81.1%) and a reasonable forward P/E of 14.44, the company faces liquidity constraints (Quick Ratio: 0.68) and high leverage (Debt/Equity: 1.38). Analysts recommend a 'buy' with a $62.69 target, implying upside, but insider selling and inconsistent earnings beats (0/4 recent quarters) temper optimism. The stock trades above the Graham Number ($34.5) but below intrinsic value ($77.29), suggesting mixed valuation signals.